Michael Martin Breen - CEO and Director, Director at GT Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and Director, Director
Issuer Symbol
GTBP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Martin Breen since 18 May 2025

Holdings reported by Michael Martin Breen for GT Biopharma, Inc.

Form 4 holding CEO and Director, Director

GT Biopharma, Inc.

Security class
Option to purchase Common Stock
Shares / value
100,000
Estimated value
Report date
04 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Michael Martin Breen for GT Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .